Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
BMC Cancer|May 27, 2008
Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer familiesKatri Pylkäs, Hannele Erkko, Jenni Nikkilä, et al.BMC Cancer|December 23, 2009
Mutation analysis of the AATF gene in breast cancer familiesMaria Haanpää, Mervi Reiman, Jenni Nikkilä, et al.Cancer Letters|January 18, 2011
Screening for large genomic rearrangements in the FANCA gene reveals extensive deletion in a Finnish breast cancer familySzilvia Solyom, Robert Winqvist, Jenni Nikkilä, et al.Human Molecular Genetics|May 21, 2010
Inactivation of Palb2 gene leads to mesoderm differentiation defect and early embryonic lethality in micePia Rantakari, Jenni Nikkilä, Heli Jokela, et al.Nature Communications|October 25, 2013
Heterozygous mutations in PALB2 cause DNA replication and damage response defectsJenni Nikkilä, Ann Christin Parplys, Katri Pylkäs, et al.Science Translational Medicine|February 24, 2012
Breast cancer-associated Abraxas mutation disrupts nuclear localization and DNA damage response functionsSzilvia Solyom, Bernadette Aressy, Katri Pylkäs, et al.Oncogene|April 12, 2018
BRD4 facilitates replication stress-induced DNA damage responseJingwen Zhang, Austin M Dulak, Maureen M Hattersley, et al.Molecular Cancer Therapeutics|June 23, 2021
Radiopotentiation Profiling of Multiple Inhibitors of the DNA Damage Response for Early Clinical DevelopmentSonja J Gill, Paul W G Wijnhoven, Jacqueline H L Fok, et al.British Journal of Cancer|May 24, 2017
Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cellsJenni Nikkilä, Rahul Kumar, James Campbell, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Penetrance analysis of the PALB2 c.1592delT founder mutationHannele Erkko, James G Dowty, Jenni Nikkilä, et al.Pageof 2